欧盟法规
ECHA物质C&L通报REACH预注册上下游产品
formic acid norbornene norbornene norborn-2-eneexo-2-norbornanol 合成工艺路线路线简述
- 合成目标产物 Exo-2-Norbornyl Formate 主要起始原料 Norbornene And Formic Acid
- (文献来源)合成步骤主要原料 Norbornene 和 Formic Acid
海关参考信息
- 2905122000-异丙醇
2912110000-甲醛
2915110000-甲酸
2905141000-异丁醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-6982344-B2
优先权日:2000-10-18
标 题:Process for preparation of optically active sulfonamides and intermediates for their synthesis
发明人:IKEMOTO TOMOMI; NISHIGUCHI ATSUKO; TOMIMATSU KIMINORI
权利人:TAKEDA PHARMACEUTICAL
摘要:A method including resolution of a diastereomeric mixture represented by the formula n n nwherein R 1 and R 2 are the same or different and each is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, only one of R 1 and R 2 contains one asymmetric carbon, and R a is an optically active and optionally substituted hydrocarbon group or an optically active and optionally substituted heterocyclic group, or a salt thereof, to produce the diastereomer having a steric configuration of the asymmetric carbon for R 1 or R 2 of an R configuration or an S configuration, or a salt thereof.
专利号:US-2004049041-A1
优先权日:2000-10-18
标 题 :Process for preparation of optically active sulfonamides and intermediates for their synthesis
专利号:WO-9855085-A1
优先权日:1997-06-04
标题:Pharmaceutical compositions and methods
发明人:BROWN DAVID A; KHORLIN ALEXANDER A; LESIAK KRYSTYNA; REN WU YUN
权利人:CODON PHARMACEUTICALS INC; BROWN DAVID A; KHORLIN ALEXANDER A; LESIAK KRYSTYNA; REN WU YUN
摘要:Disclosed are methods and compositions for regulating the melanin content of mammalian melanocytes; regulating pigmentation in mammalian skin, hair, wool or fur; treating or preventing various skin and proliferative disorders; increasing the differentiation of mammalian neuronal cells for purposes of treating neurodegenerative diseases or nerve damage; and stimulating cellular nitric oxide (NO) synthesis, cyclic guanosine monophosphate levels (cGMP), and protein kinase G (PKG) activity for purposes of treating diseases mediated by deficiencies in the NO/cGMP/PKG signal transduction pathway; by administration of various compounds, including alcohols, diols and/or triols and their analogues.
专利号:EP-1334966-B1
优先权日:2000-10-18
标题:Process for preparation of optically active sulfonamides and intermediates for their synthesis
专利号:EP-1334966-A1
优先权日:2000-10-18
标 题 :Process for preparation of optically active sulfonamides and intermediates for their synthesis